Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Fish and Richardson
Queensland Health

Generated: March 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020977

« Back to Dashboard

NDA 020977 describes ZIAGEN, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ZIAGEN profile page.

The generic ingredient in ZIAGEN is abacavir sulfate. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the abacavir sulfate profile page.
Summary for 020977
Applicant:Viiv Hlthcare
Ingredient:abacavir sulfate
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 020977
Suppliers and Packaging for NDA: 020977
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZIAGEN abacavir sulfate TABLET;ORAL 020977 NDA ViiV Healthcare Company 49702-221 N 49702-221-44
ZIAGEN abacavir sulfate TABLET;ORAL 020977 NDA ViiV Healthcare Company 49702-221 N 49702-221-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 300MG BASE
Approval Date:Dec 17, 1998TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Nov 14, 2018Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.